查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511833

潜伏性结核感染检测市场规模、份额和趋势分析报告：按品牌、测试类型、应用、最终用途、地区和细分市场预测，2024-2030 年

Latent Tuberculosis Infection Detection Market Size, Share & Trends Analysis Report By Brand (QFT-Plus), By Test Type, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10个工作天内

价格

潜伏性结核感染检测市场成长与趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球潜伏性结核感染检测市场规模预计将达到 26.3 亿美元。

预计2024年至2030年该市场将以5.44%的复合年增长率扩张。潜伏性结核感染疾病（LTBI）导致活动性疾病的风险不断增加，加上全球老年人口的快速增加，是市场成长的主要驱动力之一。此外，人们对结核病检测的认识不断提高，以及政府为有效诊断和筛检结核病感染而采取的各种倡议，也是促进市场扩张的因素之一。例如，2021 年 7 月，UKHSA 和英格兰 NHS 启动了一项减少该国结核病病例的五年计画。

市场成长的驱动力是全球老年人口的增加。例如，根据美国健康排名2021年老年人口报告，美国65岁以上人口超过5,400万，占全国人口的16.5%。老年人更容易感染潜伏性结核病。政策制定者和公共卫生官员正在改善政策，以改善全国老年人的健康。

此外，主要组织为促进结核病诊断和检测而持续提供的财政支持也有望促进市场成长。例如，Unitaid 是一家领先的卫生组织，致力于寻找疾病的快速解决方案。 2022 年 9 月，国际药品采购机制启动了 3,000 万美元的资助，以加速结核病检测。这笔资金将支持当日检测的开发，也将有助于开发新的结核病诊断技术。

同样，全球基金为控制结核病、疟疾和爱滋病毒等感染疾病提供支持和资金。该组织为结核病防治提供了全球约76%的资金，并在结核病控制方面投资约85亿美元。此外，2021 年 8 月，全球基金向 FIND 提供资金，以加速印度的结核病诊断和预防。这项投资优化了结核病早期诊断实验室的质量，提高了国家结核病诊断能力。

此外，增加全球检测工作以促进结核病感染的诊断预计将支持市场扩张。例如，QIAGEN NV 于 2022 年 3 月宣布，自推出以来已售出 1 亿份 QuantiFERON 血液检测。此后，该公司决定扩大规模，将 QuantiFERON 带给世界各地更多的患者。此外，各大公司为扩大市场占有率所采取的各种策略性措施也是推动市场扩张的因素之一。例如，2021 年 10 月，QIAGEN 宣布获得 CE 标誌核准，并部署用于诊断结核感染的 QIAreach QuantiFERON-TB 测试。

潜伏性结核感染检测市场报告重点：

  • 按测试类型划分，由于各公共卫生机构对 IGRA 的建议不断增加，预计 IGRA 产业在预测期内将以最快的速度成长。
  • 从应用来看，由于爱滋病毒感染者罹患结核病的风险增加，爱滋病毒感染者在 2023 年占据了最大的销售份额。
  • 诊断实验室部门是 2023 年收益贡献最大的部门。另一方面，学术和研究机构部门预计在预测期内将呈现最快的复合年增长率。
  • 由于市场参与企业增加投资和研究活动活性化，预计亚太地区将在预测期内呈现最快的成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章潜伏性结核感染检测市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
    • 市场机会分析
    • 未满足需求分析
  • 潜伏性结核感染检测市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 价格分析
    • 定量分析

第四章潜伏性结核感染检测市场：品牌评估与趋势分析

  • 全球潜伏性结核感染检测市场：品牌仪表板
  • 全球潜伏性结核感染检测市场：品牌变化分析
  • 全球潜伏性结核感染检测市场：依品牌、按收益
  • QFT-Plus（Quantiferon TB Gold Plus）
  • 其他的

第五章潜伏性结核感染检测市场：检测类型的估算与趋势分析

  • 全球潜伏性结核感染检测市场：测试类型仪表板
  • 全球潜伏性结核感染检测市场：测试类型变异分析
  • 全球潜伏性结核感染检测市场：按测试类型和收益
  • 结核菌素皮肤试验（TST）
  • 干扰素γ释放测定（IGRA）

第六章潜伏性结核感染检测市场：应用估计与趋势分析

  • 全球潜伏性结核感染检测市场：应用仪表板
  • 全球潜伏性结核感染检测市场：应用变化分析
  • 全球潜伏性结核感染检测市场：按应用和收益
  • 家庭接触结核病
  • 爱滋病毒感染者
  • 其他的

第七章潜伏性结核感染检测市场：最终用途估计与趋势分析

  • 全球潜伏性结核感染检测市场：最终用途仪表板
  • 全球潜伏性结核感染检测市场：最终用途变化分析
  • 全球潜伏性结核感染检测市场：依最终用途、按收益
  • 诊断实验室
  • 医院/诊所
  • 学术/研究机构

第八章潜伏性结核感染检测市场：按产品类型、技术和最终用途进行的区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模及预测趋势分析：
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第9章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023年主要企业市场占有率分析
    • QIAGEN
    • BIOMERIEUX
    • Oxford Immunotec
    • SD Biosensor, INC.
    • Wantai BioPharm
    • Lionex GmbH
    • Sanofi
    • Serum Institute of India Pvt. Ltd
    • ARKRAY, Inc.
    • Par Pharmaceutical, Inc.
Product Code: GVR-4-68039-994-9

Latent Tuberculosis Infection Detection Market Growth & Trends:

The global latent tuberculosis infection detection market size is expected to reach USD 2.63 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.44% from 2024 to 2030. The increased risk of developing active disease from latent tuberculosis infection (LTBI) coupled with the surge in the geriatric population globally is one of the major driving factors for the market growth. In addition, rising awareness about TB detection and various government initiatives for effective diagnosis and screening of tuberculosis infection is another factor contributing to market expansion. For instance, in July 2021, the UKHSA and NHS of England launched a 5-year plan to decrease TB cases in the country.

The market growth is fueled by the increase in the geriatric population across the globe. For instance, according to the elderly population report of America's Health Rankings 2021, more than 54 million population aged more than 65 years in the U.S. which accounts for 16.5% of the country's population. The geriatric population is highly susceptible to developing latent TB infection. Policymakers and public health officials are making improvements in policies to improve the health of older in the country.

Furthermore, ongoing funding activities by leading organizations to promote the diagnosis and testing for tuberculosis are also expected to fuel market growth. For instance, Unitaid is a leading health agency engaged in discovering quick solutions for diseases. In September 2022, the Unitaid launched funding of USD 30 million to boost tuberculosis detection. This funding will support the development of same-day tests and also help in the development of novel diagnostic technologies for tuberculosis.

Similarly, the Global Fund provides support and funding for the management of infectious diseases such as tuberculosis, malaria, and HIV. The organization provides around 76% of global financing for tuberculosis and it has invested around USD 8.5 billion for the management of tuberculosis. Furthermore, in August 2021, the Global Fund provide funds to FIND for the advancement of TB diagnosis and prevention in India. This investment optimized laboratory quality for early diagnosis of TB and improved tuberculosis diagnostic capacity in the country.

In addition, the rising testing efforts globally to promote the diagnosis of TB infection are expected to support market expansion. For instance, in March 2022, QIAGEN N.V. announced that the company has sold 100 million QuantiFERON blood tests since its launch. After this, the company decided to expand QuantiFERON to reach more patients across the globe. Moreover, various strategic initiatives undertaken by leading players to enhance their market share are another factor facilitating market expansion. For instance, in October 2021, QIAGEN announced CE mark approval and roll-out of the QIAreach QuantiFERON-TB test for tuberculosis infection diagnosis.

Latent Tuberculosis Infection Detection Market Report Highlights:

  • In test type, the IGRA segment is expected to grow at the fastest rate over the forecast period owing to increasing recommendations for IGRAs from various public health authorities
  • Based on application segment, the PLHIV accounted for the largest revenue share in 2023 due to the rising risk of developing TB in people suffering from HIV infection
  • The diagnostic laboratories segment was the highest revenue contributor in 2023. Whereas the academic and research institutions segment is expected to exhibit the fastest CAGR during the projected period
  • Asia Pacific is expected to exhibit the fastest growth over the forecast period due to the rising investments by market players and increasing research activities in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Brand
    • 1.2.2. Test Type
    • 1.2.3. Application
    • 1.2.4. End-use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Brand and test type outlook
    • 2.2.2. Application and end-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Latent Tuberculosis Infection Detection Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing risk of developing active tuberculosis infection from LTBI
      • 3.2.1.2. Increasing funding programs to promote TB diagnosis
      • 3.2.1.3. Favorable government initiatives for combating TB
      • 3.2.1.4. Surge in geriatric population
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Presence of stringent rules and regulations pertaining to diagnosis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Unmet need analysis
  • 3.3. Latent Tuberculosis Infection Detection Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environment landscape
    • 3.3.3. Pricing Analysis
    • 3.3.4. Volume Analysis

Chapter 4. Latent Tuberculosis Infection Detection Market: Brand Estimates & Trend Analysis

  • 4.1. Global Latent Tuberculosis Infection Detection Market: Brand Dashboard
  • 4.2. Global Latent Tuberculosis Infection Detection Market: Brand Movement Analysis
  • 4.3. Global Latent Tuberculosis Infection Detection Market by brand, Revenue
  • 4.4. QFT-Plus (QuantiFERON-TB Gold Plus)
    • 4.4.1. QFT-Plus (QuantiFERON-TB Gold Plus) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Latent Tuberculosis Infection Detection Market: Test Type Estimates & Trend Analysis

  • 5.1. Global Latent Tuberculosis Infection Detection Market: Test Type Dashboard
  • 5.2. Global Latent Tuberculosis Infection Detection Market: Test Type Movement Analysis
  • 5.3. Global Latent Tuberculosis Infection Detection Market by Test Type, Revenue
  • 5.4. Tuberculin Skin Test (TST)
    • 5.4.1. Tuberculin Skin Test (TST) market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Interferon Gamma Released Assay (IGRA)
    • 5.5.1. Interferon Gamma Released Assay (IGRA) market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Latent Tuberculosis Infection Detection Market: Application Estimates & Trend Analysis

  • 6.1. Global Latent Tuberculosis Infection Detection Market: Application Dashboard
  • 6.2. Global Latent Tuberculosis Infection Detection Market: Application Movement Analysis
  • 6.3. Global Latent Tuberculosis Infection Detection Market by Application, Revenue
  • 6.4. Household Contacts with Pulmonary TB
    • 6.4.1. Household contacts with pulmonary TB market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. PLHIV
    • 6.5.1. PLHIV market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Latent Tuberculosis Infection Detection Market: End-use Estimates & Trend Analysis

  • 7.1. Global Latent Tuberculosis Infection Detection Market: End-use Dashboard
  • 7.2. Global Latent Tuberculosis Infection Detection Market: End-use Movement Analysis
  • 7.3. Global Latent Tuberculosis Infection Detection Market by End-use, Revenue
  • 7.4. Diagnostic Laboratories
    • 7.4.1. Diagnostic laboratories market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Hospitals/Clinics
    • 7.5.1. Hospitals/Clinics market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Academic & Research Institutions
    • 7.6.1. Academic & research institutions market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Latent Tuberculosis Infection Detection Market: Regional Estimates & Trend Analysis by Product Type, Technology, and End-use

  • 8.1. Regional Dashboard
  • 8.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.6. Norway
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.9. Netherlands
      • 8.4.9.1. Key country dynamics
      • 8.4.9.2. Regulatory framework/ reimbursement structure
      • 8.4.9.3. Competitive scenario
      • 8.4.9.4. Netherlands market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.10. Belgium
      • 8.4.10.1. Key country dynamics
      • 8.4.10.2. Regulatory framework/ reimbursement structure
      • 8.4.10.3. Competitive scenario
      • 8.4.10.4. Belgium market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.11. Finland
      • 8.4.11.1. Key country dynamics
      • 8.4.11.2. Regulatory framework/ reimbursement structure
      • 8.4.11.3. Competitive scenario
      • 8.4.11.4. Finland market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.12. Luxembourg
      • 8.4.12.1. Key country dynamics
      • 8.4.12.2. Regulatory framework/ reimbursement structure
      • 8.4.12.3. Competitive scenario
      • 8.4.12.4. Luxembourg market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.4.13. Iceland
      • 8.4.13.1. Key country dynamics
      • 8.4.13.2. Regulatory framework/ reimbursement structure
      • 8.4.13.3. Competitive scenario
      • 8.4.13.4. Iceland market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.5.7. Singapore
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework/ reimbursement structure
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.5.8. Bangladesh
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework/ reimbursement structure
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Bangladesh market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.6.2. Mexico
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.6.3. Argentina
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2023
    • 9.3.4. QIAGEN
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. BIOMERIEUX
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Oxford Immunotec
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. SD Biosensor, INC.
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Wantai BioPharm
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Lionex GmbH
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Sanofi
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Serum Institute of India Pvt. Ltd
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. ARKRAY, Inc.
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
    • 9.3.13. Par Pharmaceutical, Inc.
      • 9.3.13.1. Company overview
      • 9.3.13.2. Financial performance
      • 9.3.13.3. Product benchmarking
      • 9.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America latent tuberculosis infection detection market, by region, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 3 North America latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 4 North America latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 5 North America latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 6 North America latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 7 U.S. latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 8 U.S. latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 9 U.S. latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 10 U.S. latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 11 Canada latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 12 Canada latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 13 Canada latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 14 Canada latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 15 Europe latent tuberculosis infection detection market, by region, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 16 Europe latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 17 Europe latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 18 Europe latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 19 Europe latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 20 Germany latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 21 Germany latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 22 Germany latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 23 Germany latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 24 UK latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 25 UK latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 26 UK latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 27 UK latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 28 France latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 29 France latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 30 France latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 31 France latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 32 Italy latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 33 Italy latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 34 Italy latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 35 Italy latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 36 Spain latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 37 Spain latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 38 Spain latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 39 Spain latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 40 Denmark latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 41 Denmark latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 42 Denmark latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 43 Denmark latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 44 Sweden latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 45 Sweden latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 46 Sweden latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 47 Sweden latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 48 Norway latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 49 Norway latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 50 Norway latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 51 Norway latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 52 Netherlands latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 53 Netherlands latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 54 Netherlands latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 55 Netherlands latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 56 Belgium latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 57 Belgium latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 58 Belgium latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 59 Belgium latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 60 Finland latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 61 Finland latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 62 Finland latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 63 Finland latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 64 Luxembourg latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 65 Luxembourg latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 66 Luxembourg latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 67 Luxembourg latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 68 Iceland latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 69 Iceland latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 70 Iceland latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 71 Iceland latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 72 Asia Pacific latent tuberculosis infection detection market, by region, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 73 Asia Pacific latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 74 Asia Pacific latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 75 Asia Pacific latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 76 Aisa Pacific latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 77 China latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 78 China latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 79 China latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 80 China latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 81 Japan latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 82 Japan latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 83 Japan latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 84 Japan latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 85 India latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 86 India latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 87 India latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 88 India latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 89 South Korea latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 90 South Korea latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 91 South Korea latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 92 South Korea latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 93 Australia latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 94 Australia latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 95 Australia latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 96 Australia latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 97 Thailand latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 98 Thailand latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 99 Thailand latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 100 Thailand latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 101 Singapore latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 102 Singapore latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 103 Singapore latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 104 Singapore latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 105 Bangladesh latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 106 Bangladesh latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 107 Bangladesh latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 108 Bangladesh latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 109 Latin America latent tuberculosis infection detection market, by region, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 110 Latin America latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 111 Latin America latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 112 Latin America latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 113 Latin America latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 114 Brazil latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 115 Brazil latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 116 Brazil latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 117 Brazil latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 118 Mexico latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 119 Mexico latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 120 Mexico latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 121 Mexico latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 122 Argentina latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 123 Argentina latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 124 Argentina latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 125 Argentina latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 126 MEA latent tuberculosis infection detection market, by region, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 127 MEA latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 128 MEA latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 129 MEA latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 130 MEA latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 131 South Africa latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 132 South Africa latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 133 South Africa latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 134 South Africa latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 135 Saudi Arabia latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 136 Saudi Arabia latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 137 Saudi Arabia latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 138 Saudi Arabia latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 139 UAE latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 140 UAE latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 141 UAE latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 142 UAE latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 143 Kuwait latent tuberculosis infection detection market, by brand, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 144 Kuwait latent tuberculosis infection detection market, by test type, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 145 Kuwait latent tuberculosis infection detection market, by application, 2018 - 2030 (USD Million) (Number of Tests in Thousands)
  • Table 146 Kuwait latent tuberculosis infection detection market, by end-use, 2018 - 2030 (USD Million) (Number of Tests in Thousands)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Latent tuberculosis infection detection market: market outlook
  • Fig. 14 Latent tuberculosis infection detection competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Latent tuberculosis infection detection market driver impact
  • Fig. 18 Latent tuberculosis infection detection market restraint impact
  • Fig. 19 Latent tuberculosis infection detection market: Brand movement analysis
  • Fig. 20 Latent tuberculosis infection detection market: Brand outlook and key takeaways
  • Fig. 21 QFT-Plus (QuantiFERON-TB Gold Plus) market estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 22 Others estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 23 Latent tuberculosis infection detection market: Test type movement analysis
  • Fig. 24 Latent tuberculosis infection detection market: Test type outlook and key takeaways
  • Fig. 25 Tuberculin Skin Test (TST) market estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 26 Interferon Gamma Released Assay (IGRA) estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 27 Latent tuberculosis infection detection market: Application movement analysis
  • Fig. 28 Latent tuberculosis infection detection market: Application outlook and key takeaways
  • Fig. 29 Household contacts with pulmonary TB market estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 30 PLHIV estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 31 Others estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 32 Latent tuberculosis infection detection market: End-use movement analysis
  • Fig. 33 Latent tuberculosis infection detection market: End-use outlook and key takeaways
  • Fig. 34 Diagnostics laboratories estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 35 Hospital/Clinics market estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 36 Academic & research institutions market estimates and forecast, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 37 Global latent tuberculosis infection detection market: Regional movement analysis
  • Fig. 38 Global latent tuberculosis infection detection market: Regional outlook and key takeaways
  • Fig. 39 Global latent tuberculosis infection detection market share and leading players
  • Fig. 40 North America, by country
  • Fig. 41 North America market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 42 U.S. key country dynamics
  • Fig. 43 U.S. market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 44 Canada key country dynamics
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 46 Europe market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 47 UK key country dynamics
  • Fig. 48 UK market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 49 Germany key country dynamics
  • Fig. 50 Germany market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 51 France key country dynamics
  • Fig. 52 France market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 53 Italy key country dynamics
  • Fig. 54 Italy market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 55 Spain key country dynamics
  • Fig. 56 Spain market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 57 Denmark key country dynamics
  • Fig. 58 Denmark market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 59 Sweden key country dynamics
  • Fig. 60 Sweden market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 61 Norway key country dynamics
  • Fig. 62 Norway market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 63 Netherlands key country dynamics
  • Fig. 64 Netherlands market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 65 Belgium key country dynamics
  • Fig. 66 Belgium market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 67 Finland key country dynamics
  • Fig. 68 Finland market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 69 Luxembourg key country dynamics
  • Fig. 70 Luxembourg market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 71 Iceland key country dynamics
  • Fig. 72 Iceland market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 73 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 74 China key country dynamics
  • Fig. 75 China market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 76 Japan key country dynamics
  • Fig. 77 Japan market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 78 India key country dynamics
  • Fig. 79 India market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 80 Thailand key country dynamics
  • Fig. 81 Thailand market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 82 South Korea key country dynamics
  • Fig. 83 South Korea market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 84 Australia key country dynamics
  • Fig. 85 Australia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 86 Singapore key country dynamics
  • Fig. 87 Singapore market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 88 Bangladesh key country dynamics
  • Fig. 89 Bangladesh market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 90 Latin America market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 91 Brazil key country dynamics
  • Fig. 92 Brazil market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 93 Mexico key country dynamics
  • Fig. 94 Mexico market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 95 Argentina key country dynamics
  • Fig. 96 Argentina market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 97 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 98 South Africa key country dynamics
  • Fig. 99 South Africa market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 100 Saudi Arabia key country dynamics
  • Fig. 101 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 102 UAE key country dynamics
  • Fig. 103 UAE market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 104 Kuwait key country dynamics
  • Fig. 105 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million) (Number of tests in thousands)
  • Fig. 106 Market share of key market players - Latent tuberculosis infection detection market